{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:31:46Z","timestamp":1791498706606,"version":"4.3.4"},"reference-count":86,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.neo.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T03:45:53Z","timestamp":1525405553000},"page":"574-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma"],"prefix":"10.1016","volume":"20","author":[{"given":"Xiaoxiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganiraju C.","family":"Manyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausar","family":"Jabbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dybkaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youli","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy L.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.L.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Han","family":"van Krieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooryung","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s J.M.","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben M.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane N.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun Y.","family":"Xu-Monette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2018.03.002_bb0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neo.2018.03.002_bb0010","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia","volume":"23","author":"Sehn","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2018.03.002_bb0015","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era","volume":"28","author":"Gisselbrecht","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2018.03.002_bb0020","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2006-04-016907","article-title":"Role of phosphatidylinositol 3 '-kinase\/AKT pathway in diffuse large B-cell lymphoma survival","volume":"108","author":"Uddin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.neo.2018.03.002_bb0025","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2141.2010.08123.x","article-title":"High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"149","author":"Hasselblom","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.neo.2018.03.002_bb0030","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: Navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neo.2018.03.002_bb0035","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1021\/bi702114w","article-title":"PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes","volume":"47","author":"Redfern","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.neo.2018.03.002_bb0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymeth.2014.10.002","article-title":"Study of PTEN subcellular localization","volume":"77-78","author":"Bononi","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.neo.2018.03.002_bb0045","doi-asserted-by":"crossref","first-page":"48627","DOI":"10.1074\/jbc.C100556200","article-title":"Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex","volume":"276","author":"Vazquez","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neo.2018.03.002_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","article-title":"Essential role for nuclear PTEN in maintaining chromosomal integrity","volume":"128","author":"Shen","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neo.2018.03.002_bb0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cell.2006.11.040","article-title":"Ubiquitination regulates PTEN nuclear import and tumor suppression","volume":"128","author":"Trotman","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neo.2018.03.002_bb0060","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1158\/0008-5472.CAN-05-0124","article-title":"Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein","volume":"65","author":"Chung","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0065","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/iju.12571","article-title":"PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer","volume":"21","author":"Mithal","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.neo.2018.03.002_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccr.2004.06.022","article-title":"PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients","volume":"6","author":"Nagata","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2018.03.002_bb0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s10147-014-0707-1","article-title":"Low PTEN expression is associated with worse overall survival in head and neck squamous cell carcinoma patients treated with chemotherapy and cetuximab","volume":"20","author":"da Costa","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.neo.2018.03.002_bb0080","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1158\/1078-0432.CCR-14-1027","article-title":"Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB\/C melanoma patients with BRAFV600 mutations","volume":"20","author":"Bucheit","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0085","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/cncr.0678","article-title":"Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma","volume":"94","author":"Tachibana","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2018.03.002_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-230X-8-56","article-title":"Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival","volume":"8","author":"Sawai","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.neo.2018.03.002_bb0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1309\/AJCPR11DEAYPTUSL","article-title":"Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer","volume":"141","author":"Dean","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.neo.2018.03.002_bb0100","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/sj.bjc.6604680","article-title":"Is PTEN loss associated with clinical outcome measures in human prostate cancer?","volume":"99","author":"McCall","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neo.2018.03.002_bb0105","first-page":"4183","article-title":"Somatic mutations of PTEN in glioblastoma multiforme","volume":"57","author":"Wang","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0110","first-page":"3935","article-title":"Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies","volume":"57","author":"Tashiro","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0115","first-page":"811","article-title":"Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas","volume":"4","author":"Wang","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0120","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/sj.onc.1201855","article-title":"Point mutation and homozygous deletion of PTEN\/MMAC1 in primary bladder cancers","volume":"16","author":"Cairns","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2018.03.002_bb0125","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jamaoncol.2016.0891","article-title":"Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19784 Diverse Solid Tumors","volume":"2","author":"Millis","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.neo.2018.03.002_bb0130","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neo.2018.03.002_bb0135","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1305656110","article-title":"PTEN loss defines a PI3K\/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma","volume":"110","author":"Pfeifer","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neo.2018.03.002_bb0140","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3109\/10428194.2010.502584","article-title":"PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma","volume":"51","author":"Liu","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.neo.2018.03.002_bb0145","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1080\/10428190701636443","article-title":"Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: Higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN","volume":"48","author":"Fridberg","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.neo.2018.03.002_bb0150","first-page":"14875","article-title":"Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL","volume":"8","author":"Ma","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.neo.2018.03.002_bb0155","doi-asserted-by":"crossref","first-page":"66237","DOI":"10.18632\/oncotarget.19889","article-title":"PIK3CA amplification and PTEN loss in diffused large B-cell lymphoma","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2018.03.002_bb0160","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/leu.2012.83","volume":"26","author":"Visco","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.neo.2018.03.002_bb0165","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","article-title":"Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study","volume":"120","author":"Xu-Monette","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.neo.2018.03.002_bb0170","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.ajpath.2017.04.009","article-title":"AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma","volume":"187","author":"Wang","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neo.2018.03.002_bb0175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.neo.2018.03.002_bb0180","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.2015.118","article-title":"Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"28","author":"Xu-Monette","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.neo.2018.03.002_bb0185","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1158\/1078-0432.CCR-14-0683","article-title":"Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma","volume":"20","author":"Ok","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0190","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood-2012-12-473702","article-title":"MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program","volume":"122","author":"Xu-Monette","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.neo.2018.03.002_bb0195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.18632\/aging.100898","article-title":"p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function","volume":"8","author":"Xu-Monette","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neo.2018.03.002_bb0200","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/leu.2016.243","article-title":"Loss of PRDM1\/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma","volume":"31","author":"Xia","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.neo.2018.03.002_bb0205","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1182\/blood-2016-05-715094","article-title":"Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma","volume":"128","author":"Xu-Monette","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.neo.2018.03.002_bb0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jtbi.2006.06.017","article-title":"PQN and DQN: algorithms for expression microarrays","volume":"243","author":"Liu","year":"2006","journal-title":"J Theor Biol"},{"key":"10.1016\/j.neo.2018.03.002_bb0215","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.18632\/aging.100855","article-title":"The PTEN tumor suppressor gene and its role in lymphoma pathogenesis","volume":"7","author":"Wang","year":"2015","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neo.2018.03.002_bb0220","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/modpathol.2015.94","article-title":"Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy","volume":"28","author":"Liu","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.neo.2018.03.002_bb0225","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","article-title":"Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Kiyasu","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.neo.2018.03.002_bb0230","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81663-3","article-title":"Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association","volume":"99","author":"Lee","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neo.2018.03.002_bb0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cellsig.2011.08.013","article-title":"Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K\/mTOR\/p70S6K pathway by interacting of VEGFR-2","volume":"24","author":"Rho","year":"2012","journal-title":"Cell Signal"},{"key":"10.1016\/j.neo.2018.03.002_bb0240","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1158\/1078-0432.CCR-12-0845","article-title":"Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas","volume":"18","author":"Gonzalez-Aguilar","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0245","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN transcription by p53","volume":"8","author":"Stambolic","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.neo.2018.03.002_bb0250","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","article-title":"The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways","volume":"67","author":"Feng","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0255","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.celrep.2016.04.083","article-title":"IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC","volume":"15","author":"Ennajdaoui","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.neo.2018.03.002_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033684","article-title":"Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era","volume":"7","author":"Carico","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2018.03.002_bb0265","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2016-10-747303","article-title":"Tonic B-cell receptor signaling in diffuse large B-cell lymphoma","volume":"130","author":"Havranek","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.neo.2018.03.002_bb0270","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood-2016-12-758599","article-title":"Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL","volume":"130","author":"Erdmann","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.neo.2018.03.002_bb0275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ejh.12427","article-title":"B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells","volume":"94","author":"Seda","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.neo.2018.03.002_bb0280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.seminhematol.2015.01.008","article-title":"B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma","volume":"52","author":"Young","year":"2015","journal-title":"Semin Hematol"},{"key":"10.1016\/j.neo.2018.03.002_bb0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/cr.2008.284","article-title":"BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten","volume":"19","author":"Cheng","year":"2009","journal-title":"Cell Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0290","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1128\/MCB.00310-08","article-title":"PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression","volume":"28","author":"Chang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neo.2018.03.002_bb0295","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.cdd.4402073","article-title":"Nuclear PTEN: a tale of many tails","volume":"14","author":"Gil","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neo.2018.03.002_bb0300","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1038\/onc.2008.241","article-title":"PTEN: a new guardian of the genome","volume":"27","author":"Yin","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2018.03.002_bb0305","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm.4062","article-title":"PTEN opposes negative selection and enables oncogenic transformation of pre-B cells","volume":"22","author":"Shojaee","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.neo.2018.03.002_bb0310","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.20021101","article-title":"Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination","volume":"197","author":"Suzuki","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.neo.2018.03.002_bb0315","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1440-1789.2010.01178.x","article-title":"Homozygous 10q23\/PTEN deletion and its impact on outcome in glioblastoma: a prospective translational study on a uniformly treated cohort of adult patients","volume":"31","author":"Srividya","year":"2011","journal-title":"Neuropathology"},{"key":"10.1016\/j.neo.2018.03.002_bb0320","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1182\/blood.V92.9.3410","article-title":"PTEN gene alterations in lymphoid neoplasms","volume":"92","author":"Sakai","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.neo.2018.03.002_bb0325","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/path.1611","article-title":"The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome","volume":"204","author":"Panigrahi","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.neo.2018.03.002_bb0330","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1309\/YT58WWMTA6YR1PRV","article-title":"Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome","volume":"124","author":"Slipicevic","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.neo.2018.03.002_bb0335","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/mc.20420","article-title":"Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray","volume":"47","author":"Harris","year":"2008","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.neo.2018.03.002_bb0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molcel.2005.03.008","article-title":"PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth","volume":"18","author":"Gao","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.neo.2018.03.002_bb0345","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1200\/JCO.2011.37.4751","article-title":"Regulation, role, and targeting of Akt in cancer","volume":"29","author":"Davies","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2018.03.002_bb0350","first-page":"188","article-title":"The PI3K\/Akt Pathway in Tumors of Endocrine Tissues","volume":"6","author":"Robbins","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.neo.2018.03.002_bb0355","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/MCB.00319-13","article-title":"PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2","volume":"33","author":"Patsoukis","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neo.2018.03.002_bb0360","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/0008-5472.CAN-12-2522","article-title":"MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase","volume":"73","author":"Kaur","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0365","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.18632\/oncotarget.14123","article-title":"MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2018.03.002_bb0370","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.celrep.2016.05.084","article-title":"A c-Myc\/miR17-92\/Pten Axis Controls PI3K-Mediated Positive and Negative Selection in B Cell Development and Reconstitutes CD19 Deficiency","volume":"16","author":"Benhamou","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.neo.2018.03.002_bb0375","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-1119(99)00206-1","article-title":"PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation","volume":"235","author":"Ghosh","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.neo.2018.03.002_bb0380","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1074\/jbc.M805183200","article-title":"PTEN deletion and concomitant c-Myc activation do not lead to tumor formation in pancreatic beta cells","volume":"284","author":"Radziszewska","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neo.2018.03.002_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2015.27","article-title":"The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Down-Regulation of the Target Gene PTEN are Associated with Primary Cutaneous B-cell Lymphoma Progression","author":"Battistella","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.neo.2018.03.002_bb0390","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccr.2009.10.014","article-title":"miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation","volume":"16","author":"Garofalo","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2018.03.002_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101899","article-title":"miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma","volume":"9","author":"Tejero","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2018.03.002_bb0400","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","article-title":"Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas","volume":"113","author":"Malumbres","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.neo.2018.03.002_bb0405","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm1517","article-title":"Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma","volume":"13","author":"Parsa","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.neo.2018.03.002_bb0410","doi-asserted-by":"crossref","first-page":"21609","DOI":"10.18632\/oncotarget.15450","article-title":"The miR-25-93-106b cluster regulates tumor metastasis and immune evasion via modulation of CXCL12 and PD-L1","volume":"8","author":"Cioffi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2018.03.002_bb0415","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.humimm.2014.01.006","article-title":"MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer","volume":"75","author":"Zhu","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.neo.2018.03.002_bb0420","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2017.163","article-title":"MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs","author":"Pyzer","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.neo.2018.03.002_bb0425","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2018.03.002_bb0430","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558618300137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558618300137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T15:22:16Z","timestamp":1604244136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558618300137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1476558618300137"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2018.03.002","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}